Gilead Wins Sovaldi Domain Dispute Over Buyers’ Club Generic Sellers16/02/2018 By William New, Intellectual Property Watch Leave a CommentPharmaceutical company Gilead has made headlines in recent years for offering the hepatitis C drug Sovaldi that has helped many patients. And for the fact that it came with an eye-popping price tag. Perhaps in a sign of the times, Gilead this month won an open-and-shut case against a squatter on the domain name “sovaldi.eu,” that was offering lower-priced generic versions of Sovaldi, including through links to “buyers’ clubs” organised to obtain medicines more affordably. The website was called, “SOVALDI. The life-saving cure for Hepatitis C which nobody can afford.” Was it a little act of rebellion, or just another internet opportunist?